Recent progress in the therapeutic management of pre-eclampsia.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 15500369)

Published in Expert Opin Pharmacother on November 01, 2004

Authors

Delia Maria Paternoster1, Sara Fantinato, Francesca Manganelli, Umberto Nicolini, Massimo Milani, Antonio Girolami

Author Affiliations

1: University of Padova, Department of Gynaecology and Human Reproduction, Via Giustiniani 3, 35128 Padova, Italy. paternod@unipd.it

Articles by these authors

Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med (2004) 3.74

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood (2002) 3.59

Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med (2002) 3.51

An association between atherosclerosis and venous thrombosis. N Engl J Med (2003) 3.39

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. Blood (2002) 1.78

Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis. Thromb Haemost (2003) 1.46

The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified. J Thromb Thrombolysis (2009) 1.38

The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood (2002) 1.23

A randomized controlled study comparing harmonic versus electrosurgery in laparoscopic myomectomy. Fertil Steril (2009) 1.19

Heparin-induced thrombocytopenia: a review. Semin Thromb Hemost (2006) 1.12

Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab (2002) 1.10

Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. Blood (2002) 1.02

Apparent diffusion coefficient determination in normal fetal brain: a prenatal MR imaging study. AJNR Am J Neuroradiol (2003) 1.00

Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial. Int J Dermatol (2003) 0.98

The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ (2004) 0.96

C-reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb Hemost (2006) 0.95

Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study. Curr Med Res Opin (2007) 0.94

An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. Blood (2002) 0.93

The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost (2002) 0.93

D-dimer before chemotherapy might predict venous thromboembolism. Blood Coagul Fibrinolysis (2009) 0.92

Rebuttal: factor XII levels, factor XII 46 C>T polymorphism and venous thrombosis: a word of caution is needed. Thromb Haemost (2004) 0.92

Prenatal magnetic resonance imaging of rhombencephalosynapsis and associated brain anomalies: report of 3 cases. J Comput Assist Tomogr (2004) 0.90

Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Arch Intern Med (2002) 0.89

Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor. Haematologica (2003) 0.86

Prenatal magnetic resonance imaging evaluation of ischemic brain lesions in the survivors of monochorionic twin pregnancies: report of 3 cases. J Comput Assist Tomogr (2004) 0.85

Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. J Eur Acad Dermatol Venereol (2006) 0.85

Efficacy and tolerability of a new chlorhexidine-based vaginal gel in vaginal infections. Curr Med Res Opin (2004) 0.85

The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia. Clin Appl Thromb Hemost (2003) 0.84

Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol. Blood Coagul Fibrinolysis (2003) 0.84

Efficacy of a new aluminium salt thermophobic foam in the treatment of axillary and palmar primary hyperhidrosis: a pilot exploratory trial. Curr Med Res Opin (2005) 0.83

The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts. Ann Allergy Asthma Immunol (2009) 0.83

Does hemophilia protect against atherosclerosis? A case-control study. Clin Appl Thromb Hemost (2006) 0.83

Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders. Haematologica (2005) 0.83

Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura. Blood (2004) 0.83

The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood (2002) 0.82

Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism. Thromb Haemost (2004) 0.82

Cervical phIGFBP-1 in the evaluation of the risk of preterm delivery. Acta Obstet Gynecol Scand (2007) 0.81

Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations. Blood (2002) 0.81

Genetic study in patients with factor XII deficiency: a report of three new mutations exon 13 (Q501STOP), exon 14 (P547L) and -13C>T promoter region in three compound heterozygotes. Blood Coagul Fibrinolysis (2008) 0.81

Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population. Thromb Haemost (2005) 0.81

Prenatal diagnosis of vein of Galen aneurysmal malformations. Fetal Diagn Ther (2003) 0.80

Efficacy of sublingual specific immunotherapy in patients with respiratory allergy to Alternaria alternata: a randomised, assessor-blinded, patient-reported outcome, controlled 3-year trial. Curr Med Res Opin (2010) 0.80

Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial. Pediatr Allergy Immunol (2009) 0.80

A large family from Argentina with prekallikrein deficiency due to a compound heterozygosis (T insertion in intron 7 and Asp558Glu in exon 15): prekallikrein Cordoba. Am J Hematol (2010) 0.79

Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383Trp stop codon and Cys529Tyr). Thromb Haemost (2003) 0.79

An urea, arginine and carnosine based cream (Ureadin Rx Db ISDIN) shows greater efficacy in the treatment of severe xerosis of the feet in Type 2 diabetic patients in comparison with glycerol-based emollient cream. A randomized, assessor-blinded, controlled trial. BMC Dermatol (2012) 0.79

Fetal serum beta2-microglobulin before and after bladder shunting: a 2-step approach to evaluate fetuses with lower urinary tract obstruction. J Urol (2007) 0.79

Influence of the Alu-repeat I/D polymorphism in t-PA gene intron 8 on the stimulated t-PA release after venous occlusion. Clin Appl Thromb Hemost (2003) 0.78

Type IIb von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunction. Clin Appl Thromb Hemost (2007) 0.78

A multicenter, randomized, parallel-group trial assessing compliance, tolerability, safety, and efficacy to treatment with grass allergy tablets in 261 patients with grass pollen rhinoconjunctivitis. J Allergy (Cairo) (2011) 0.78

The lack of ties between north-eastern Italy and African-Americans suggest a multi-founder effect for FVII Padua (Arg304Gln) disorder. Blood Coagul Fibrinolysis (2010) 0.78

Investigation of endothelin-1 type A receptor gene polymorphism (-231 G > A) in preeclampsia susceptibility. J Matern Fetal Neonatal Med (2007) 0.78

FXII deficiency is neither a cause of thrombosis nor a protection from thrombosis. Am J Ophthalmol (2005) 0.78

Different genotypes are responsible for the normal Russell viper venom assays seen in some cases of congenital factor X deficiency. Am J Hematol (2008) 0.77

Sensitivity and specificity of different skin prick tests with latex extracts in pediatric patients with suspected natural rubber latex allergy--a cohort study. Pediatr Allergy Immunol (2008) 0.77

Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy. Transplantation (2003) 0.77

Efficacy of AT in pre-eclampsia: a case-control prospective trial. Thromb Haemost (2004) 0.77

Should we explain lower urinary tract symptoms to patients? Neurourol Urodyn (2008) 0.77

Successful treatment of bacterial vaginosis with a policarbophil-carbopol acidic vaginal gel: results from a randomised double-blind, placebo-controlled trial. Eur J Obstet Gynecol Reprod Biol (2005) 0.77

Human cytomegalovirus (HCMV) DNAemia in the mother at amniocentesis as a risk factor for iatrogenic HCMV infection of the fetus. J Infect Dis (2008) 0.76

Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy. Expert Rev Clin Immunol (2011) 0.76

Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease. Blood Coagul Fibrinolysis (2014) 0.76

Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: a prospective, randomised, investigator-blinded, comparative trial vs. permethrin cream. Eur J Dermatol (2003) 0.76

Are antiphospholipid antibodies an independent risk factor for atherosclerosis? Clin Appl Thromb Hemost (2002) 0.76

Fetal pleural effusion. Prenat Diagn (2007) 0.76

Selection of both normal and bleeding patients is indicated before desmopressin administration. Thromb Haemost (2005) 0.75

Mutations are no substitutes for clotting, chromogenic and immunological assays in patients with congenital prothrombin deficiency. Am J Hematol (2008) 0.75

The spectrum of factor VII deficiencies and abnormalities. Blood Coagul Fibrinolysis (2004) 0.75

A comment about the correct attribution of the discovery of FX Friuli disorder. Clin Appl Thromb Hemost (2012) 0.75

Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy. J Allergy Clin Immunol (2009) 0.75

Local rhamnosoft, ceramides and L-isoleucine in atopic eczema: a randomized, placebo controlled trial. Pediatr Allergy Immunol (2014) 0.75

Oral contraceptives, thrombosis and socio-ethical values: an inevitable compromise is needed based mainly on a careful evaluation of potential users. Clin Appl Thromb Hemost (2005) 0.75

The use of tissue thromboplastins of different origin is a fundamental tool in the initial characterization of FVII defects on "factor VII deficiency (Semin Thromb Hemost 2009;35(4):400-406)". Semin Thromb Hemost (2010) 0.75

Arg 304 Gln (FVII Padua) and Ala 294 Val mutations are equally present in patients with FVII deficiency and thrombosis. Eur J Haematol (2011) 0.75

Attempt to improve the diagnosis of immune thrombocytopenia by combined use of two different platelet autoantibodies assays (PAIgG and MACE). Haematologica (2002) 0.75

The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study. Blood Coagul Fibrinolysis (2009) 0.75

Difficulties in the mutation analysis of plasminogen gene: a study in two patients with ligneous conjunctivitis. Clin Appl Thromb Hemost (2006) 0.75

A large deletion due to a new mutation (intron 13/exon 23) in a sporadic case of severe hemophilia A. Clin Appl Thromb Hemost (2004) 0.75

Bleeding manifestations apparently unrelated to coagulation or other organic disorders: A tentative classification and diagnostic clues. Hematology (2013) 0.75

The safety of a novel sublingual rush induction phase for latex desensitization. Curr Med Res Opin (2010) 0.75

A novel type I factor X variant (factor X Cys350Phe) due to loss of a disulfide bond in the catalytic domain. Blood Coagul Fibrinolysis (2003) 0.75

Recurrent thromboembolism in fertile women with venous thrombosis: incidence and risk factors. Thromb Haemost (2003) 0.75

Ex vivo testing of a temperature- and pressure-controlled amnio-irrigator for fetoscopic surgery. J Pediatr Surg (2002) 0.75

Conformation sensitive gel electrophoresis for detection of factor X gene mutations. Thromb Res (2002) 0.75

Thrombocytosis and recurrent hepatic outflow obstruction (Budd-Chiari syndrome) after successful thrombolysis: case report and literature review. Clin Appl Thromb Hemost (2002) 0.75

Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia. Haematologica (2002) 0.75

Effect of delivery modalities on the physiologic inhibition system of coagulation of the neonate. Thromb Res (2002) 0.75

Efficacy of topical 10% urea-based lotion in patients with ichthyosis vulgaris: a two-center, randomized, controlled, single-blind, right-vs.-left study in comparison with standard glycerol-based emollient cream. Curr Med Res Opin (2011) 0.75

Discrepancies between clotting and chromogenic assays in congenital coagulation disorders: the hemostatic coin has only one face, chromogenic substrates many. Blood Coagul Fibrinolysis (2009) 0.75

Prenatal ultrasound detection of bilateral focal polymicrogyria. Prenat Diagn (2004) 0.75

Arterial thrombosis and drospirenone-containing pill (Yasmin). Is the pill to be absolutely avoided by women who smoke? J Thromb Thrombolysis (2007) 0.75

Ballantyne syndrome: a case report. Fetal Diagn Ther (2006) 0.75